Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Gastric cancer (GC) accounts for 10% of cancer deaths worldwide [1]; median survival is 10–12 months in advanced cases [2]. Chemotherapy is the standard treatment of the majority of GC patients, however a subset of patients who harbor HER2 amplification are candidates for HER2-targeted therapy.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
